Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BCEL

Atreca (BCEL)

Atreca Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCEL
DateTimeSourceHeadlineSymbolCompany
12/03/202407:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCELAtreca Inc
12/03/202407:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
07/02/202408:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
06/01/202408:57Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:BCELAtreca Inc
27/12/202300:39Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCELAtreca Inc
27/12/202300:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
27/12/202300:30GlobeNewswire Inc.Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to ImmunomeNASDAQ:BCELAtreca Inc
15/11/202308:30GlobeNewswire Inc.Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic AlternativesNASDAQ:BCELAtreca Inc
28/09/202309:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
21/09/202322:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
21/09/202322:00GlobeNewswire Inc.Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb CrossNASDAQ:BCELAtreca Inc
15/09/202306:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
18/08/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCELAtreca Inc
17/08/202307:20Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BCELAtreca Inc
11/08/202306:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCELAtreca Inc
11/08/202306:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCELAtreca Inc
11/08/202306:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
11/08/202306:05GlobeNewswire Inc.Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate RestructuringNASDAQ:BCELAtreca Inc
05/08/202308:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
05/08/202308:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
19/07/202323:18Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCELAtreca Inc
16/06/202308:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
16/06/202308:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
16/06/202308:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
16/06/202308:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
16/06/202308:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
16/06/202308:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
16/06/202308:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
16/06/202306:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
05/06/202322:00GlobeNewswire Inc.Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual MeetingNASDAQ:BCELAtreca Inc
 Showing the most relevant articles for your search:NASDAQ:BCEL